Where the Severely Injured Rebuild Their Lives: Inside Asia’s Premier Trauma Recovery Hub
Yangpyeong Station in Gyeonggi Province is actively served by both the KTX and the Seoul metropolitan subway.
Search results for "patient safety"
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood
Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T) therapies, announced on June 15 that...
RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks
Myocardial infarction and unstable angina are life-threatening medical emergencies that occur when the blood vessels...
The Four-Minute Miracle: How a Tiny Daily Workout Protects Senior Independence
For many older adults, aging announces itself in small, restrictive ways. A trip to the local supermarket—even if it is...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Overestimating the Body: Why South Korea’s Aging Generations Face a Sudden Surge in Disability
“Society as a whole needs to pay closer attention to the safety of baby boomers and the so-called 386 generation.
Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight
For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms...
Asan Medical Center Breaks Ground on Korea’s Largest Heavy-Ion Cancer Therapy Center
Asan Medical Center is bringing heavy-ion therapy—one of the world's most advanced weapons against cancer—to its...
Mixing Meds and Supplements: Why Red Ginseng Demands Caution for Diabetics
Dietary supplements concentrate health-promoting ingredients into convenient, everyday forms.
Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence
"I had surgery and I even went through radiation—so why did it come back?" Families of glioblastoma patients face this...